arrow_back Civic Audit
Share share

Expanded Research and Education for Endometrial Cancer

This act aims to boost research into endometrial cancer and enhance public education on the topic. It focuses on reducing disparities in diagnosis and treatment, especially among African-American women, potentially leading to better health outcomes and increased public awareness.
Key points
Increased funding for endometrial cancer research, including studies on disparities in incidence and mortality.
Establishment of public education programs, specifically targeting African-American women, about symptoms, risk factors, and available treatments.
Requirement for clinical trials on endometrial cancer to include African-American women participants to ensure representativeness and treatment effectiveness for all groups.
Coordination among various public health institutions to streamline research and educational efforts.
article Official text account_balance Process page notifications_active Track this Bill
Status: Expired
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 118_HR_10439
Sponsor: Rep. Scott, David [D-GA-13]
Process start date: 2024-12-16
System Note: Lustra is free, publicly auditable civic infrastructure — full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Endometrial Cancer Research and Education Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_10439.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-12-16.

What are the main provisions?

Key points include:

  • Increased funding for endometrial cancer research, including studies on disparities in incidence and mortality.
  • Establishment of public education programs, specifically targeting African-American women, about symptoms, risk factors, and available treatments.
  • Requirement for clinical trials on endometrial cancer to include African-American women participants to ensure representativeness and treatment effectiveness for all groups.
  • Coordination among various public health institutions to streamline research and educational efforts.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Scott, David [D-GA-13].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health